BRUSSELS, Feb 9 (Reuters) - Meta Platforms on Monday criticised EU regulators after they charged the U.S. tech giant with breaching antitrust rules and threaten to halt its block on AI rivals on its messaging service WhatsApp.
"The facts are that there is no reason for the EU to intervene in the WhatsApp Business API. There are many AI options and people can use them from app stores, operating systems, devices, websites, and industry... (continue reading...)
Feb 9 (Reuters) - Shares of Kroger rose about 6% in premarket trading on Monday after a Wall Street Journal report said the grocery chain has picked former Walmart executive Greg Foran as its CEO, a year after the ouster of Rodney McMullen.
Kroger removed McMullen last March after a board investigation found that his personal conduct was "inconsistent" with certain company policies.
The CEO announcement could come as early as Monday,... (continue reading...)
By Saqib Iqbal Ahmed and Lewis Krauskopf
NEW YORK, Feb 9 (Reuters) - The software and services industry's recent plunge has ignited fears that the artificial intelligence boom may be reshaping markets in unexpected ways, raising questions about whether a rotation out of technology stocks signals trouble ahead for the AI trade.
Financial markets, juiced for months with investor enthusiasm about the artificial intelligence trade, got a... (continue reading...)
By Isla Binnie
Feb 9 (Reuters) - Apollo Global Management reported a 13% rise in fourth-quarter profit on Monday, buoyed by inflows of fresh client money and strong debt origination.
The New York-based alternative asset manager posted adjusted net income of $1.54 billion, or $2.47 per share, for the last three months of the year. That compares with $1.36 billion, or $2.22 per share, a year earlier.
Quarterly growth was... (continue reading...)
Investing.com -- Novo Nordisk (CSE:NOVOb) shares rose sharply on Monday after telehealth company Hims Hers Health (NYSE: HIMS) pulled its newly launched $49 compounded weight-loss pill over the weekend, following legal pressure from the Danish drugmaker and the U.S. Food and Drug Administration (FDA).
Shares in Novo surged more than 8% in Copenhagen trading by 04:48 ET (09:48 GMT), while its U.S.-listed shares jumped 6.5% in premarket trading.
Hims Hers, meanwhile,... (continue reading...)
More General News
View Older Stories-
Alibaba’s Qwen pauses AI shopping coupons after 10 mln orders flood system
-
Cleveland-Cliffs shares drop as revenue misses expectations
-
Dynatrace leaps 10% after raising annual outlook, beating FQ3 estimates
-
Morgan Stanley says buy these 9 AI-hit software stocks on discount
-
Descartes Systems Group (DSGX) Showcases AI Innovations to Help Improve Supply Chain and Logistics Operations
-
Trans Canada Gold Corp. Grants Incentive Stock Options
-
Cango Inc. (CANG) Completes Bitcoin Sale to Strengthen Financial Position and Advance AI Transformation
-
XPeng Inc. (XPEV) XPENG and Ant International’s Antom Advance Global Collaboration to Improve Digital Payment Experience for EV Charging
-
Comstock Mining (LODE) Metals Awarded Tax Abatement From the Nevada Governor’s Office of Economic Development
-
Victory Capital (VCTR) Announces Upcoming Investor Conference Appearances
-
GXO Logistics, Inc. (GXO) Selected to Manage Operations at BMW Group’s Swindon Site
-
MannKind (MNKD) Announces First Patient Enrolled in INHALE-1ST Pediatric Study Evaluating Afrezza® for Youth with Newly-Diagnosed Type 1 Diabetes (T1D)
-
Reitar Logtech Holdings Limited (RITR) Signs Strategic Cooperation Framework Agreement with Optimize Integration Group, First-year Procurement Target of RMB 1 Billion
-
TotalEnergies (TTE) to Provide 1 GW of Solar Capacity to Power Google’s Data Centers in Texas for 15 Years
-
Ripple effects of software rout felt through asset managers
-
Goldman Sachs teams up with Anthropic to automate banking tasks with AI agents, CNBC reports
-
Pulse Biosciences stock rises after positive cardiac catheter study data
-
Alpha Modus CEO positions patent portfolio at the center of in-store retail AI
-
US consumer sentiment rises to six-month high in early February
-
Micron stock dips as analyst slashes Nvidia HBM4 supply forecast to zero
-
Wall St rebounds after week-long tech rout, Amazon down on AI capex jump
-
Amazon stock slides 9% premarket as 2026 capex guidance blows past expectations
-
Philip Morris forecasts higher profits, shrugging off threats from rivals
-
Philip Morris International falls as Q4 results meet expectations
-
Under Armour edges higher as fiscal Q3 earnings, guidance top forecasts
-
Under Armour lifts annual forecasts as turnaround slows N America sales slide
-
Tesla is training its AI technology in China, local media reports
-
Carlyle allays software fears, private-equity deals boost profit
-
Biogen forecasts upbeat annual profit, eyes 2028 launch of key drugs
-
Tech stock shakeout clouds market ahead of economic data deluge
-
Exclusive-Citigroup aims to complete work on consent orders this year, sources say
-
US equity fund inflows ease as tech selloff weighs
-
AI is not a bubble, senior executive at Nvidia supplier Wistron says
-
Coty shifts focus to core brands under new CEO, withdraws full-year outlook
-
News Corp beats quarterly revenue estimates on growth in Dow Jones unit
-
Saylor-led Strategy's quarterly losses widen as bitcoin faces another reckoning
-
Atlassian shares dip as cloud growth expected to slow despite earnings beat
-
Roblox shares soar 20% as bookings guidance tops estimates
-
New Brunswick government quits Elon Musk’s X over safety concerns
-
Roblox forecasts strong annual bookings as gaming platform momentum grows; shares jump
-
Reddit forecasts strong revenue as AI tools drive ad sales
-
Canada Goose shares tumble as margin slump overshadows revenue beat
-
Silicon Valley’s Y Combinator reverses policy on Canadian startup incorporation
-
Novocure stock falls after CMS revokes billing privileges
-
Steve Madden down 9% as Jefferies downgrades stock on wholesale headwinds
-
Verizon consumer division head departing as company mounts turnaround effort
-
Citizens lifts Uber rating on valuation and AV strategy
-
Tech analyst calls valuation in this big chip stock a rare “gift” for investors
-
Hims offers cheapest GLP-1 weight-loss pill in US in a shock to Novo, Lilly
-
BMO sets 2026 year-end target of 7,380 for S&P 500
